European pharmaceutical research and development: Could public infrastructure overcome market failures?

Author: Florio, M., Pancotti, C., & Prochazka, D.

Date: 2021

Language: English

Learn More: https://www.europarl.europa.eu/stoa/en/document/EPRS_STU(2021)697197

You might also enjoy

Private finance and the threat to global health

Late disclosures of federal funding in US patents

Drug Dealing: Making Public Pharma Work

Reclaiming drug discovery: why we need public pharma

Sweden’s new antibiotic factory could serve as EU and NATO strategic asset

Open drug pricing activist MSF signs secrecy pacts with Big Pharma